schliessen

Filtern

 

Bibliotheken

Cover Image

Acceptability of a COVID-19 vaccine among adults in the United States: How many people would get vaccinated?

Coronavirus disease 2019 (COVID-19) was declared a pandemic in March 2020. Several prophylactic vaccines against COVID-19 are currently in development, yet little is known about people’s acceptability of a COVID-19 vaccine. We conducted an online survey of adults ages 18 and older in the United Stat... Full description

Journal Title: Vaccine 2020-09-29, Vol.38 (42), p.6500-6507
Main Author: Reiter, Paul L
Other Authors: Pennell, Michael L , Katz, Mira L
Format: Electronic Article Electronic Article
Language: English
Subjects:
Acceptability
Adolescent
Adult
Adults
Betacoronavirus - drug effects
Betacoronavirus - immunology
Betacoronavirus - pathogenicity
Coronavirus
Coronavirus Infections - epidemiology
Coronavirus Infections - immunology
Coronavirus Infections - prevention & control
Coronavirus Infections - psychology
Coronavirus Infections - virology
Coronaviruses
COVID-19
COVID-19 Vaccines
Cross-Sectional Studies
Epidemics
Health care industry
Health insurance
Health Knowledge, Attitudes, Practice
Humans
Immunization
Immunogenicity, Vaccine
Infections
Male
Medical research
Medicine, Experimental
Middle Aged
Pandemics
Pandemics - prevention & control
Patient Compliance - psychology
Patient Compliance - statistics & numerical data
Patient Safety
Pneumonia, Viral - epidemiology
Pneumonia, Viral - immunology
Pneumonia, Viral - prevention & control
Pneumonia, Viral - virology
Public health
Risk Assessment - trends
SARS-CoV-2
Treatment Refusal - psychology
Treatment Refusal - statistics & numerical data
United States - epidemiology
Vaccination
Vaccination - psychology
Vaccine
Vaccines
Viral diseases
Viral Vaccines - administration & dosage
Quelle: Alma/SFX Local Collection
Publisher: Netherlands: Elsevier Ltd
ID: ISSN: 0264-410X
Link: https://www.ncbi.nlm.nih.gov/pubmed/32863069
Zum Text:
SendSend as email Add to Book BagAdd to Book Bag
Staff View
recordid: cdi_proquest_miscellaneous_2438994371
title: Acceptability of a COVID-19 vaccine among adults in the United States: How many people would get vaccinated?
format: Article
creator:
  • Reiter, Paul L
  • Pennell, Michael L
  • Katz, Mira L
subjects:
  • Acceptability
  • Adolescent
  • Adult
  • Adults
  • Betacoronavirus - drug effects
  • Betacoronavirus - immunology
  • Betacoronavirus - pathogenicity
  • Coronavirus
  • Coronavirus Infections - epidemiology
  • Coronavirus Infections - immunology
  • Coronavirus Infections - prevention & control
  • Coronavirus Infections - psychology
  • Coronavirus Infections - virology
  • Coronaviruses
  • COVID-19
  • COVID-19 Vaccines
  • Cross-Sectional Studies
  • Epidemics
  • Health care industry
  • Health insurance
  • Health Knowledge, Attitudes, Practice
  • Humans
  • Immunization
  • Immunogenicity, Vaccine
  • Infections
  • Male
  • Medical research
  • Medicine, Experimental
  • Middle Aged
  • Pandemics
  • Pandemics - prevention & control
  • Patient Compliance - psychology
  • Patient Compliance - statistics & numerical data
  • Patient Safety
  • Pneumonia, Viral - epidemiology
  • Pneumonia, Viral - immunology
  • Pneumonia, Viral - prevention & control
  • Pneumonia, Viral - virology
  • Public health
  • Risk Assessment - trends
  • SARS-CoV-2
  • Treatment Refusal - psychology
  • Treatment Refusal - statistics & numerical data
  • United States - epidemiology
  • Vaccination
  • Vaccination - psychology
  • Vaccine
  • Vaccines
  • Viral diseases
  • Viral Vaccines - administration & dosage
ispartof: Vaccine, 2020-09-29, Vol.38 (42), p.6500-6507
description: Coronavirus disease 2019 (COVID-19) was declared a pandemic in March 2020. Several prophylactic vaccines against COVID-19 are currently in development, yet little is known about people’s acceptability of a COVID-19 vaccine. We conducted an online survey of adults ages 18 and older in the United States (n = 2,006) in May 2020. Multivariable relative risk regression identified correlates of participants’ willingness to get a COVID-19 vaccine (i.e., vaccine acceptability). Overall, 69% of participants were willing to get a COVID-19 vaccine. Participants were more likely to be willing to get vaccinated if they thought their healthcare provider would recommend vaccination (RR = 1.73, 95% CI: 1.49–2.02) or if they were moderate (RR = 1.09, 95% CI: 1.02–1.16) or liberal (RR = 1.14, 95% CI: 1.07–1.22) in their political leaning. Participants were also more likely to be willing to get vaccinated if they reported higher levels of perceived likelihood getting a COVID-19 infection in the future (RR = 1.05, 95% CI: 1.01–1.09), perceived severity of COVID-19 infection (RR = 1.08, 95% CI: 1.04–1.11), or perceived effectiveness of a COVID-19 vaccine (RR = 1.46, 95% CI: 1.40–1.52). Participants were less likely to be willing to get vaccinated if they were non-Latinx black (RR = 0.81, 95% CI: 0.74–0.90) or reported a higher level of perceived potential vaccine harms (RR = 0.95, 95% CI: 0.92–0.98). Many adults are willing to get a COVID-19 vaccine, though acceptability should be monitored as vaccine development continues. Our findings can help guide future efforts to increase COVID-19 vaccine acceptability (and uptake if a vaccine becomes available).
language: eng
source: Alma/SFX Local Collection
identifier: ISSN: 0264-410X
fulltext: fulltext
issn:
  • 0264-410X
  • 1873-2518
url: Link


@attributes
NO1
SEARCH_ENGINEprimo_central_multiple_fe
SEARCH_ENGINE_TYPEPrimo Central Search Engine
RANK2.902372
LOCALfalse
PrimoNMBib
record
control
sourceidgale_proqu
recordidTN_cdi_proquest_miscellaneous_2438994371
sourceformatXML
sourcesystemPC
galeidA640477204
sourcerecordidA640477204
originalsourceidFETCH-LOGICAL-c372t-ce7f6f0cf6923fa2c44ff28a2181e4c57a56496e0035867de4c6d393e7f6e8443
addsrcrecordideNqFkU2LFDEQhoMo7jj6E5SAFy_d5qvTaS_LMH7swsIedMVbyCaVMUN3p-2kd5l_b4YZPXiROhQUz1v1Ui9CrympKaHy_b5-MNaGEWpGGKmJqongT9CKqpZXrKHqKVoRJkUlKPlxgV6ktCeENJx2z9EFZ0pyIrsV6jfWwpTNfehDPuDoscHb2-_XHyva4fMFbIY47rBxS58TDiPOPwHfjSGDw1-zyZA-4Kv4iAczHvAEceoBP8ald3gH-bykUO7yJXrmTZ_g1bmv0d3nT9-2V9XN7Zfr7eamsrxlubLQeumJ9bJj3BtmhfCeKcOooiBs05pGik4CIbxRsnVlJh3v-FEGSgi-Ru9Oe6c5_logZT2EZKHvzQhxSZoJrrpO8JYW9O0_6D4u81jcFapgrWDFxBrVJ2pnetBh9DHPxpZyMAQbR_ChzDdSENG2jBwdNCeBnWNKM3g9zWEw80FToo_56b0-f1cf89NE6SIrujdnO8v9AO6v6k9gBbg8AVD-9xBg1skGGC24MIPN2sXwnxO_ARjFrEg
sourcetypeAggregation Database
isCDItrue
recordtypearticle
pqid2443874292
display
typearticle
titleAcceptability of a COVID-19 vaccine among adults in the United States: How many people would get vaccinated?
sourceAlma/SFX Local Collection
creatorReiter, Paul L ; Pennell, Michael L ; Katz, Mira L
creatorcontribReiter, Paul L ; Pennell, Michael L ; Katz, Mira L
descriptionCoronavirus disease 2019 (COVID-19) was declared a pandemic in March 2020. Several prophylactic vaccines against COVID-19 are currently in development, yet little is known about people’s acceptability of a COVID-19 vaccine. We conducted an online survey of adults ages 18 and older in the United States (n = 2,006) in May 2020. Multivariable relative risk regression identified correlates of participants’ willingness to get a COVID-19 vaccine (i.e., vaccine acceptability). Overall, 69% of participants were willing to get a COVID-19 vaccine. Participants were more likely to be willing to get vaccinated if they thought their healthcare provider would recommend vaccination (RR = 1.73, 95% CI: 1.49–2.02) or if they were moderate (RR = 1.09, 95% CI: 1.02–1.16) or liberal (RR = 1.14, 95% CI: 1.07–1.22) in their political leaning. Participants were also more likely to be willing to get vaccinated if they reported higher levels of perceived likelihood getting a COVID-19 infection in the future (RR = 1.05, 95% CI: 1.01–1.09), perceived severity of COVID-19 infection (RR = 1.08, 95% CI: 1.04–1.11), or perceived effectiveness of a COVID-19 vaccine (RR = 1.46, 95% CI: 1.40–1.52). Participants were less likely to be willing to get vaccinated if they were non-Latinx black (RR = 0.81, 95% CI: 0.74–0.90) or reported a higher level of perceived potential vaccine harms (RR = 0.95, 95% CI: 0.92–0.98). Many adults are willing to get a COVID-19 vaccine, though acceptability should be monitored as vaccine development continues. Our findings can help guide future efforts to increase COVID-19 vaccine acceptability (and uptake if a vaccine becomes available).
identifier
0ISSN: 0264-410X
1EISSN: 1873-2518
2DOI: 10.1016/j.vaccine.2020.08.043
3PMID: 32863069
languageeng
publisherNetherlands: Elsevier Ltd
subject
ispartofVaccine, 2020-09-29, Vol.38 (42), p.6500-6507
rights
02020 Elsevier Ltd
1Copyright © 2020 Elsevier Ltd. All rights reserved.
2COPYRIGHT 2020 Elsevier B.V.
32020. Elsevier Ltd
lds50peer_reviewed
oafree_for_read
citesFETCH-LOGICAL-c372t-ce7f6f0cf6923fa2c44ff28a2181e4c57a56496e0035867de4c6d393e7f6e8443
links
openurl$$Topenurl_article
openurlfulltext$$Topenurlfull_article
thumbnail$$Usyndetics_thumb_exl
backlink$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32863069$$D View this record in MEDLINE/PubMed
search
creatorcontrib
0Reiter, Paul L
1Pennell, Michael L
2Katz, Mira L
title
0Acceptability of a COVID-19 vaccine among adults in the United States: How many people would get vaccinated?
1Vaccine
addtitleVaccine
descriptionCoronavirus disease 2019 (COVID-19) was declared a pandemic in March 2020. Several prophylactic vaccines against COVID-19 are currently in development, yet little is known about people’s acceptability of a COVID-19 vaccine. We conducted an online survey of adults ages 18 and older in the United States (n = 2,006) in May 2020. Multivariable relative risk regression identified correlates of participants’ willingness to get a COVID-19 vaccine (i.e., vaccine acceptability). Overall, 69% of participants were willing to get a COVID-19 vaccine. Participants were more likely to be willing to get vaccinated if they thought their healthcare provider would recommend vaccination (RR = 1.73, 95% CI: 1.49–2.02) or if they were moderate (RR = 1.09, 95% CI: 1.02–1.16) or liberal (RR = 1.14, 95% CI: 1.07–1.22) in their political leaning. Participants were also more likely to be willing to get vaccinated if they reported higher levels of perceived likelihood getting a COVID-19 infection in the future (RR = 1.05, 95% CI: 1.01–1.09), perceived severity of COVID-19 infection (RR = 1.08, 95% CI: 1.04–1.11), or perceived effectiveness of a COVID-19 vaccine (RR = 1.46, 95% CI: 1.40–1.52). Participants were less likely to be willing to get vaccinated if they were non-Latinx black (RR = 0.81, 95% CI: 0.74–0.90) or reported a higher level of perceived potential vaccine harms (RR = 0.95, 95% CI: 0.92–0.98). Many adults are willing to get a COVID-19 vaccine, though acceptability should be monitored as vaccine development continues. Our findings can help guide future efforts to increase COVID-19 vaccine acceptability (and uptake if a vaccine becomes available).
subject
0Acceptability
1Adolescent
2Adult
3Adults
4Betacoronavirus - drug effects
5Betacoronavirus - immunology
6Betacoronavirus - pathogenicity
7Coronavirus
8Coronavirus Infections - epidemiology
9Coronavirus Infections - immunology
10Coronavirus Infections - prevention & control
11Coronavirus Infections - psychology
12Coronavirus Infections - virology
13Coronaviruses
14COVID-19
15COVID-19 Vaccines
16Cross-Sectional Studies
17Epidemics
18Health care industry
19Health insurance
20Health Knowledge, Attitudes, Practice
21Humans
22Immunization
23Immunogenicity, Vaccine
24Infections
25Male
26Medical research
27Medicine, Experimental
28Middle Aged
29Pandemics
30Pandemics - prevention & control
31Patient Compliance - psychology
32Patient Compliance - statistics & numerical data
33Patient Safety
34Pneumonia, Viral - epidemiology
35Pneumonia, Viral - immunology
36Pneumonia, Viral - prevention & control
37Pneumonia, Viral - virology
38Public health
39Risk Assessment - trends
40SARS-CoV-2
41Treatment Refusal - psychology
42Treatment Refusal - statistics & numerical data
43United States - epidemiology
44Vaccination
45Vaccination - psychology
46Vaccine
47Vaccines
48Viral diseases
49Viral Vaccines - administration & dosage
issn
00264-410X
11873-2518
fulltexttrue
rsrctypearticle
creationdate2020
recordtypearticle
recordideNqFkU2LFDEQhoMo7jj6E5SAFy_d5qvTaS_LMH7swsIedMVbyCaVMUN3p-2kd5l_b4YZPXiROhQUz1v1Ui9CrympKaHy_b5-MNaGEWpGGKmJqongT9CKqpZXrKHqKVoRJkUlKPlxgV6ktCeENJx2z9EFZ0pyIrsV6jfWwpTNfehDPuDoscHb2-_XHyva4fMFbIY47rBxS58TDiPOPwHfjSGDw1-zyZA-4Kv4iAczHvAEceoBP8ald3gH-bykUO7yJXrmTZ_g1bmv0d3nT9-2V9XN7Zfr7eamsrxlubLQeumJ9bJj3BtmhfCeKcOooiBs05pGik4CIbxRsnVlJh3v-FEGSgi-Ru9Oe6c5_logZT2EZKHvzQhxSZoJrrpO8JYW9O0_6D4u81jcFapgrWDFxBrVJ2pnetBh9DHPxpZyMAQbR_ChzDdSENG2jBwdNCeBnWNKM3g9zWEw80FToo_56b0-f1cf89NE6SIrujdnO8v9AO6v6k9gBbg8AVD-9xBg1skGGC24MIPN2sXwnxO_ARjFrEg
startdate20200929
enddate20200929
creator
0Reiter, Paul L
1Pennell, Michael L
2Katz, Mira L
general
0Elsevier Ltd
1Elsevier B.V
2Elsevier Limited
scope
0CGR
1CUY
2CVF
3ECM
4EIF
5NPM
6AAYXX
7CITATION
8BSHEE
93V.
107QL
117RV
127T2
137T5
147U9
157X7
167XB
1788C
1888E
198AO
208C1
218FE
228FH
238FI
248FJ
258FK
268G5
27ABUWG
28AZQEC
29BBNVY
30BENPR
31BHPHI
32C1K
33DWQXO
34FYUFA
35GHDGH
36GNUQQ
37GUQSH
38H94
39HCIFZ
40K9-
41K9.
42KB0
43LK8
44M0R
45M0S
46M0T
47M1P
48M2O
49M7N
50M7P
51MBDVC
52NAPCQ
53PQEST
54PQQKQ
55PQUKI
56Q9U
577X8
sort
creationdate20200929
titleAcceptability of a COVID-19 vaccine among adults in the United States: How many people would get vaccinated?
authorReiter, Paul L ; Pennell, Michael L ; Katz, Mira L
facets
frbrtype5
frbrgroupidcdi_FETCH-LOGICAL-c372t-ce7f6f0cf6923fa2c44ff28a2181e4c57a56496e0035867de4c6d393e7f6e8443
rsrctypearticles
prefilterarticles
languageeng
creationdate2020
topic
0Acceptability
1Adolescent
2Adult
3Adults
4Betacoronavirus - drug effects
5Betacoronavirus - immunology
6Betacoronavirus - pathogenicity
7Coronavirus
8Coronavirus Infections - epidemiology
9Coronavirus Infections - immunology
10Coronavirus Infections - prevention & control
11Coronavirus Infections - psychology
12Coronavirus Infections - virology
13Coronaviruses
14COVID-19
15COVID-19 Vaccines
16Cross-Sectional Studies
17Epidemics
18Health care industry
19Health insurance
20Health Knowledge, Attitudes, Practice
21Humans
22Immunization
23Immunogenicity, Vaccine
24Infections
25Male
26Medical research
27Medicine, Experimental
28Middle Aged
29Pandemics
30Pandemics - prevention & control
31Patient Compliance - psychology
32Patient Compliance - statistics & numerical data
33Patient Safety
34Pneumonia, Viral - epidemiology
35Pneumonia, Viral - immunology
36Pneumonia, Viral - prevention & control
37Pneumonia, Viral - virology
38Public health
39Risk Assessment - trends
40SARS-CoV-2
41Treatment Refusal - psychology
42Treatment Refusal - statistics & numerical data
43United States - epidemiology
44Vaccination
45Vaccination - psychology
46Vaccine
47Vaccines
48Viral diseases
49Viral Vaccines - administration & dosage
toplevel
0peer_reviewed
1online_resources
creatorcontrib
0Reiter, Paul L
1Pennell, Michael L
2Katz, Mira L
collection
0Medline
1MEDLINE
2MEDLINE (Ovid)
3MEDLINE
4MEDLINE
5PubMed
6CrossRef
7Academic OneFile (A&I only)
8ProQuest Central (Corporate)
9Bacteriology Abstracts (Microbiology B)
10Nursing & Allied Health Database
11Health and Safety Science Abstracts (Full archive)
12Immunology Abstracts
13Virology and AIDS Abstracts
14Health & Medical Collection
15ProQuest Central (purchase pre-March 2016)
16Healthcare Administration Database (Alumni)
17Medical Database (Alumni Edition)
18ProQuest Pharma Collection
19Public Health Database
20ProQuest SciTech Collection
21ProQuest Natural Science Collection
22Hospital Premium Collection
23Hospital Premium Collection (Alumni Edition)
24ProQuest Central (Alumni) (purchase pre-March 2016)
25Research Library (Alumni Edition)
26ProQuest Central (Alumni Edition)
27ProQuest Central Essentials
28Biological Science Collection
29ProQuest Central
30Natural Science Collection
31Environmental Sciences and Pollution Management
32ProQuest Central Korea
33Health Research Premium Collection
34Health Research Premium Collection (Alumni)
35ProQuest Central Student
36Research Library Prep
37AIDS and Cancer Research Abstracts
38SciTech Premium Collection
39Consumer Health Database (Alumni Edition)
40ProQuest Health & Medical Complete (Alumni)
41Nursing & Allied Health Database (Alumni Edition)
42ProQuest Biological Science Collection
43Consumer Health Database
44Health & Medical Collection (Alumni Edition)
45Healthcare Administration Database
46Medical Database
47Research Library
48Algology Mycology and Protozoology Abstracts (Microbiology C)
49Biological Science Database
50Research Library (Corporate)
51Nursing & Allied Health Premium
52ProQuest One Academic Eastern Edition
53ProQuest One Academic
54ProQuest One Academic UKI Edition
55ProQuest Central Basic
56MEDLINE - Academic
jtitleVaccine
delivery
delcategoryRemote Search Resource
fulltextfulltext
addata
au
0Reiter, Paul L
1Pennell, Michael L
2Katz, Mira L
formatjournal
genrearticle
ristypeJOUR
atitleAcceptability of a COVID-19 vaccine among adults in the United States: How many people would get vaccinated?
jtitleVaccine
addtitleVaccine
date2020-09-29
risdate2020
volume38
issue42
spage6500
epage6507
pages6500-6507
issn0264-410X
eissn1873-2518
abstractCoronavirus disease 2019 (COVID-19) was declared a pandemic in March 2020. Several prophylactic vaccines against COVID-19 are currently in development, yet little is known about people’s acceptability of a COVID-19 vaccine. We conducted an online survey of adults ages 18 and older in the United States (n = 2,006) in May 2020. Multivariable relative risk regression identified correlates of participants’ willingness to get a COVID-19 vaccine (i.e., vaccine acceptability). Overall, 69% of participants were willing to get a COVID-19 vaccine. Participants were more likely to be willing to get vaccinated if they thought their healthcare provider would recommend vaccination (RR = 1.73, 95% CI: 1.49–2.02) or if they were moderate (RR = 1.09, 95% CI: 1.02–1.16) or liberal (RR = 1.14, 95% CI: 1.07–1.22) in their political leaning. Participants were also more likely to be willing to get vaccinated if they reported higher levels of perceived likelihood getting a COVID-19 infection in the future (RR = 1.05, 95% CI: 1.01–1.09), perceived severity of COVID-19 infection (RR = 1.08, 95% CI: 1.04–1.11), or perceived effectiveness of a COVID-19 vaccine (RR = 1.46, 95% CI: 1.40–1.52). Participants were less likely to be willing to get vaccinated if they were non-Latinx black (RR = 0.81, 95% CI: 0.74–0.90) or reported a higher level of perceived potential vaccine harms (RR = 0.95, 95% CI: 0.92–0.98). Many adults are willing to get a COVID-19 vaccine, though acceptability should be monitored as vaccine development continues. Our findings can help guide future efforts to increase COVID-19 vaccine acceptability (and uptake if a vaccine becomes available).
copNetherlands
pubElsevier Ltd
pmid32863069
doi10.1016/j.vaccine.2020.08.043
oafree_for_read